Intro

This chapter details a pioneering phase I clinical trial on the transplantation of human embryonic stem cell-derived dopaminergic neurons for Parkinson's disease. It highlights the promising safety outcomes and improvements in participants, as well as the importance of concurrent independent studies for validating the findings.